Screener
PTC Therapeutics PTCT US — Total Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: PTC Therapeutics’s 10-K, filed February 19, 2026.
- Filed
- Feb 19, 2026, 4:36 PM EST
- Fiscal year
- FY2025
- Accession
- 0001104659-26-017575
| Line item | United States | Non-US | Total |
|---|---|---|---|
| Total assets | $2,525,035 | $373,732 | $2,898,767 |
| Fixed assets, net | $54,109 | $1,262 | $55,371 |
| Revenue | $1,494,767 | $235,888 | $1,730,655 |
| Year Ended December 31, 2024 | |||
| United States | Non-US | Total | |
| Total assets | $1,343,234 | $361,790 | $1,705,024 |
| Fixed assets, net | $59,748 | $1,222 | $60,970 |
| Revenue | $413,044 | $393,736 | $806,780 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is PTC Therapeutics's US — total assets?
- PTC Therapeutics (PTCT) reported US — total assets of $2.53B in Q4 2025.
- How has PTC Therapeutics's US — total assets changed year-over-year?
- PTC Therapeutics's US — total assets increased by 88.0% year-over-year, from $1.34B to $2.53B.
- What does US — total assets mean?
- This metric represents the total economic resources controlled by the company that are located or utilized within the United States. It encompasses both tangible and intangible assets, such as inventory, receivables, and regional intellectual property rights. Monitoring this balance provides insight into the scale of the company's US-based operations and the capital intensity required to support its domestic business model.
Ask your AI about PTC Therapeutics's us — total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude